Potential interventions for SARS‐CoV‐2 infections: Zinc showing promise.
According to studies carried by scientists at St. Luke’s Hospital in Kansas City and UPMC Hillman Cancer Center in Pittsburgh, a combination of SARS-CoV-2 therapy with zinc supplementation reduces the mortality rate of SARS-CoV-2 by 80%. When an intensive search was conducted in the first weeks of the SARS-CoV-2 pandemic for potential agents to help…